EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sphingomyelin as a key negative mediator in atrial fibrillation via lipid profiling analysis and functional identification

Linlin Wang, Anqi Shi, Daixin Yu, Zhengmeng Jiang, Qianqian Chen iD, Xiaoxuan Yu iD, Cheng Qu, An Pan

Europace · 2026

DOI: 10.1093/europace/euag270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2026. Verfasst von Linlin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, Medical Center of Soochow University, Suz…. Hauptthemen laut MEDLINE: Sphingomyelins, Atrial Fibrillation, Lipidomics. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Scientific Research Project of Jiangsu Provincial Health Commission, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Atrial fibrillation (AF) has emerged as one of the most prevalent cardiac arrhythmias globally, with its incidence continuously rising, thereby elevating it to a major public health concern. The heart is known for its high lipid content, and disorders or abnormalities in lipid metabolism are frequently associated with cardiovascular diseases. This study aimed to investigate the regulatory roles of lipids in AF. Methods and results Using tree-based ensemble learning-assisted lipidomics, sphingomyelin was identified as a key differential metabolite and found to be significantly reduced in AF patients. Exogenous supplementation of sphingomyelin significantly attenuated acetylcholine–CaCl2-induced and angiotensin II-induced AF, fibrosis, and inflammation in mice. Furthermore, decreased sphingomyelin levels were attributed to increased activity of sphingomyelin phosphodiesterases (SMPDs) under AF conditions. Mechanistically, RNA-Seq analysis demonstrated that sphingomyelin inhibits AF-induced activation of the Rap1 signalling pathway, a finding corroborated by overexpression and knockdown of RAP1 in vivo.

Conclusion

Together, these findings highlight the therapeutic potential of sphingomyelin and SMPD inhibitors in mitigating AF through inhibition of the Rap1 signalling pathway, thereby establishing the targeting of sphingomyelin metabolism as a viable and novel treatment strategy for AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingomyelinsAtrial FibrillationLipidomicsAnimalsHumansMiceSignal TransductionMaleSphingomyelin Phosphodiesteraserap1 GTP-Binding ProteinsDisease Models, AnimalMice, Inbred C57BLLipid Metabolism

Stichwörter der Autor:innen

Atrial fibrillationLipidomicsRap1SMPDsSphingomyelin

Substanzen

SphingomyelinsSphingomyelin Phosphodiesteraserap1 GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Cardiology, the Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, Medical Center of Soochow University, Suzhou 215000, China.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID-Profile: Qianqian Chen, Xiaoxuan Yu

Förderung

  • Scientific Research Project of Jiangsu Provincial Health Commission
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Wang, L., Shi, A., Yu, D., Jiang, Z., Chen, Q., Yu, X., Qu, C., & Pan, A. (2026). Sphingomyelin as a key negative mediator in atrial fibrillation via lipid profiling analysis and functional identification. Europace. https://doi.org/10.1093/europace/euag270

Vancouver

Wang L, Shi A, Yu D, Jiang Z, Chen Q, Yu X, et al. Sphingomyelin as a key negative mediator in atrial fibrillation via lipid profiling analysis and functional identification. Europace. 2026. doi:10.1093/europace/euag270

BibTeX
@article{Wang2026,
  author = {Wang, Linlin and Shi, Anqi and Yu, Daixin and Jiang, Zhengmeng and Chen, Qianqian and Yu, Xiaoxuan and Qu, Cheng and Pan, An},
  title = {Sphingomyelin as a key negative mediator in atrial fibrillation via lipid profiling analysis and functional identification},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag270}
}
Kostenlos starten →